These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16893489)
21. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA. Eschner AK; Mugnai K Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386 [TBL] [Abstract][Full Text] [Related]
22. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Fawcett PT; Rose CD; Budd SM; Gibney KM Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199 [TBL] [Abstract][Full Text] [Related]
23. When a vaccine is safe. Nature; 2006 Feb; 439(7076):509. PubMed ID: 16452935 [No Abstract] [Full Text] [Related]
24. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170 [TBL] [Abstract][Full Text] [Related]
25. By the way, doctor. I was vaccinated against Lyme disease in 2000. Do I still need to be careful about tick bites? Robb-Nicholson C Harv Womens Health Watch; 2006 Aug; 13(12):8. PubMed ID: 17120334 [No Abstract] [Full Text] [Related]
29. Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific. Shaffer L Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19214-19217. PubMed ID: 31554734 [No Abstract] [Full Text] [Related]
30. A systematic review and meta-analysis for the adverse effects, immunogenicity and efficacy of Lyme disease vaccines: Guiding novel vaccine development. Badawi A; Shering M; Rahman S; Lindsay LR Can J Public Health; 2017 Apr; 108(1):e62-e70. PubMed ID: 28425901 [TBL] [Abstract][Full Text] [Related]
31. [Lyme disease vaccine: hopes and concerns]. Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T Pol Merkur Lekarski; 1999 Jun; 6(36):344-6. PubMed ID: 10481552 [TBL] [Abstract][Full Text] [Related]
32. [Lyme disease: prophylaxis after tick bite]. Patey O Med Mal Infect; 2007; 37(7-8):446-55. PubMed ID: 17399928 [TBL] [Abstract][Full Text] [Related]
33. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. Shapiro ED; Gerber MA; Holabird NB; Berg AT; Feder HM; Bell GL; Rys PN; Persing DH N Engl J Med; 1992 Dec; 327(25):1769-73. PubMed ID: 1435930 [TBL] [Abstract][Full Text] [Related]
35. American Academy of Pediatrics. Committee on Infecious Diseases. Prevention of Lyme disease. Pediatrics; 2000 Jan; 105(1 Pt 1):142-7. PubMed ID: 10617720 [TBL] [Abstract][Full Text] [Related]
36. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567 [TBL] [Abstract][Full Text] [Related]
37. Lyme disease in children: diagnosis, treatment, and prevention. Prose NS; Abson KG; Berg D Semin Dermatol; 1992 Mar; 11(1):31-6. PubMed ID: 1550714 [TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 months. Schoen RT; Sikand VK; Caldwell MC; Van Hoecke C; Gillet M; Buscarino C; Parenti DL Clin Ther; 2000 Mar; 22(3):315-25. PubMed ID: 10963286 [TBL] [Abstract][Full Text] [Related]
39. Protective value of prophylactic antibiotic treatment of tick bite for Lyme disease prevention: an animal model. Piesman J; Hojgaard A Ticks Tick Borne Dis; 2012 Jun; 3(3):193-6. PubMed ID: 22421585 [TBL] [Abstract][Full Text] [Related]
40. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]